FDA's Throckmorton Says There Is No "Systematic Conservatism" On Diabetes Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency data show no evidence for charges that cardiovascular guidance killed drug development, official says at ADA meeting.